Category: Press Release

GlycoNet awards $1.45 million to eight projects aimed at improving the health of Canadians

GlycoNet awards $1.45 million to eight projects aimed at improving the health of Canadians

GlycoNet awards $1.45 million to eight projects aimed at improving the health of Canadians. Funding supports glycomics translational research into post-surgical pain management, cancer diagnosis, and treatment of Parkinson’s disease, infectious diseases and chronic illness.

GlycoNet awards grants worth $90,000 to three Alberta startup companies

GlycoNet awards grants worth $90,000 to three Alberta startup companies

Glyco-based companies use funds to protect intellectual property, build business capacity EDMONTON (October 9, 2018) – The Canadian Glycomics Network (GlycoNet) awarded $90,000 in grants to three Alberta-based startup companies: 48Hour Discovery Inc., GlyCa BioSciences Inc. and PanTHERA CryoSolutions Inc. The Startup Company Funding Program recognizes the needs of start-up companies and provides financial help […]

Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery

Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery

MINNEAPOLIS, March 15, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., has secured a license agreement with 48Hour Discovery (“48HD”) which grants it access to 48HD’s ligand discovery technology. This follows a license agreement with SyntArray, LLC, announced on March 13th, and […]

en_USEnglish
fr_CAFrench en_USEnglish
Scroll to Top